Bacteria co-colonizing with Clostridioides difficile in two asymptomatic patients

被引:4
作者
Hong, Wei [1 ,2 ]
Yang, Jing [3 ]
Cheng, Yumei [4 ]
Huang, Xiaolin [5 ]
Rao, Fengqin [1 ,2 ]
Zhang, Ting [1 ,2 ]
Wang, Pixiang [6 ]
Liao, Jian [5 ]
Qi, Xiaolan [1 ,2 ]
Guan, Zhizhong [1 ,2 ]
Chen, Zhenhong [7 ]
Cui, Guzhen [7 ]
机构
[1] Guizhou Med Univ, Minist Educ, Key Lab Endem & Ethn Dis, Guiyang 55004, Guizhou, Peoples R China
[2] Guizhou Med Univ, Key Lab Med Mol Biol, Guiyang 55004, Guizhou, Peoples R China
[3] Guiyang Maternal & Child Hlth Hosp, Guiyang 550004, Guizhou, Peoples R China
[4] Guizhou Med Univ, Affiliated Hosp, Dept Crit Care Med, Guiyang 550004, Guizhou, Peoples R China
[5] Guizhou Med Univ, Sch Hosp Stomatol, Guiyang 550004, Guizhou, Peoples R China
[6] Auburn Univ, Dept Biosyst Engn, Auburn, AL 36849 USA
[7] Guizhou Med Univ, Sch Basic Med Sci, Guiyang 550025, Guizhou, Peoples R China
来源
OPEN LIFE SCIENCES | 2019年 / 14卷 / 01期
基金
中国国家自然科学基金;
关键词
Clostridium difficile infection; asymptomatic patients; co-colonization; microbial diversity; 16S rDNA sequencing; FECAL MICROBIOTA TRANSPLANTATION; INFECTION; GUT;
D O I
10.1515/biol-2019-0071
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Clostridium difficile infection (CDI) is the leading cause of nosocomial diarrhea. Co-colonization of key bacterial taxa may prevent the transition from asymptomatic C. difficile colonization to CDI. However, little is known about the composition of key bacterial taxa in asymptomatic patients. Methods: In the present study, the culture method was used to examine the composition of stool microbiota in two asymptomatic patients from Guizhou, China. Results: A total of 111 strains were isolated and phylogenetic relationships were determined by 16S ribosomal gene sequencing and Molecular Evolutionary Genetics Analysis version 7. The results demonstrated that Escherichia (33.3%, 37/111), Clostridium (24.3%, 27/111) and Enterococcus (11.7%, 13/111) exhibited a high ratio in asymptomatic patients. These isolates derived from two phyla: Firmicutes (51.3%, 57/111) and Proteobacteria (44.1%, 49/111). In addition, co-colonization of human pathogens Fusobacterium nucleatum, Ralstonia pickettii, Klebsiella pneumoniae, Klebsiella quasipneumoniae and Clostridium tertium with C. difficile was identified. To the best of our knowledge, these pathogens have not been co-isolated with C. difficile previously. Conclusions: In summary, the present study identified the composition of fecal microbiota in two asymptomatic patients in Guizhou, China. These results suggested that co-infection with human pathogens may be ubiquitous during CDI progression.
引用
收藏
页码:628 / 637
页数:10
相关论文
共 50 条
  • [41] Asymptomatic carriage of toxigenic Clostridium difficile by hospitalized patients
    Guerrero, D. M.
    Becker, J. C.
    Eckstein, E. C.
    Kundrapu, S.
    Deshpande, A.
    Sethi, A. K.
    Donskey, C. J.
    JOURNAL OF HOSPITAL INFECTION, 2013, 85 (02) : 155 - 158
  • [42] Neutralizing epitopes on Clostridioides difficile toxin A revealed by the structures of two camelid VHH antibodies
    Chen, Baohua
    Perry, Kay
    Jin, Rongsheng
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [43] A cost-utility analysis of two Clostridioides difficile infection guideline treatment pathways
    Swart, Nicholas
    Sinha, Araadhna M.
    Bentley, Anthony
    Smethurst, Helen
    Spencer, Gordon
    Ceder, Sophia
    Wilcox, Mark H.
    CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (10) : 1291 - 1297
  • [44] The Role of Probiotics in the Prevention of Clostridioides difficile Infection in Patients with Chronic Kidney Disease
    Dudzicz-Gojowy, Sylwia
    Wiecek, Andrzej
    Adamczak, Marcin
    NUTRIENTS, 2024, 16 (05)
  • [45] Outcomes and risk factors for mortality in clostridioides difficile infection in patients with NAFLD and NASH
    Patel, Ankoor H.
    Pathak, Gaurav N.
    Chen, Alexander
    Greenberg, Patricia
    Mazzaferro, Natale
    Patel, Anish
    Mallangada, Naveen
    Minacapelli, Carlos D.
    Catalano, Kaitlyn
    Suthar, Hansel
    Rustgi, Vinod K.
    ANNALS OF HEPATOLOGY, 2024, 29 (04)
  • [46] Management of Recurrent Clostridioides Infection: A Difficile Problem in Inflammatory Bowel Disease Patients
    Lam, Angela Y.
    Gutin, Liat S.
    Nguyen, Yume
    Velayos, Fernando S.
    DIGESTIVE DISEASES AND SCIENCES, 2020, 65 (11) : 3111 - 3115
  • [47] Impact of Clostridioides difficile length of treatment on rates of recurrence in patients on concurrent antibiotics
    Rajakumar, Irina
    Jaber, Rami
    Ali, Raafi
    Rennert-May, Elissa
    Sabuda, Deana
    AMERICAN JOURNAL OF INFECTION CONTROL, 2023, 51 (11) : 1213 - 1217
  • [48] A genomic survey of Clostridioides difficile isolates from hospitalized patients in Melbourne, Australia
    Larcombe, Sarah
    Williams, Galain C.
    Amy, Jacob
    Lim, Su Chen
    Riley, Thomas V.
    Muleta, Anthony
    Barugahare, Adele A.
    Powell, David R.
    Johanesen, Priscilla A.
    Cheng, Allen C.
    Peleg, Anton Y.
    Lyras, Dena
    MICROBIOLOGY SPECTRUM, 2023, 11 (06):
  • [49] Clostridioides difficile Infection in Patients after Organ Transplantation-A Narrative Overview
    Dudzicz-Gojowy, Sylwia
    Wiecek, Andrzej
    Adamczak, Marcin
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (15)
  • [50] Prevalence of Non-Toxigenic Clostridioides difficile in Diarrhoea Patients and Their Clinical Characteristics
    Jeon, Cheon-Hoo
    Kim, Si-Ho
    Wi, Yu Mi
    ANTIBIOTICS-BASEL, 2023, 12 (09):